Show simple item record

dc.contributor.authorSandu, Raluca Elena
dc.contributor.authorBalseanu, Adrian Tudor
dc.contributor.authorBogdan, Catalin
dc.contributor.authorSlevin, Mark
dc.contributor.authorPetcu, Eugen
dc.contributor.authorPopa-Wagner, Aurel
dc.date.accessioned2017-06-18T23:41:07Z
dc.date.available2017-06-18T23:41:07Z
dc.date.issued2017
dc.identifier.issn0531-5565
dc.identifier.doi10.1016/j.exger.2017.01.008
dc.identifier.urihttp://hdl.handle.net/10072/340088
dc.description.abstractStroke is a devastating disease demanding vigorous search for new therapies. Initial enthusiasm to stimulate restorative processes in the ischemic brain by means of cell-based therapies has meanwhile converted into a more balanced view recognizing impediments that may be related to unfavorable age-associated environments. Recent results using a variety of drug, cell therapy or combination thereof suggest that, (i) treatment with Granulocyte-Colony Stimulating Factor (G-CSF) in aged rats has primarily a beneficial effect on functional outcome most likely via supportive cellular processes such as neurogenesis; (ii) the combination therapy, G-CSF with mesenchymal cells (G-CSF + BM-MSC or G-CSF + BM-MNC) did not further improve behavioral indices, neurogenesis or infarct volume as compared to G-CSF alone in aged animals; (iii) better results with regard to integration of transplanted cells in the aged rat environment have been obtained using iPS of human origin; (iv) mesenchymal cells may be used as drug carriers for the aged post-stroke brains. Conclusion: While the middle aged brain does not seem to impair drug and cell therapies, in a real clinical practice involving older post-stroke patients, successful regenerative therapies would have to be carried out for a much longer time.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofpagefrom1
dc.relation.ispartofpageto5
dc.relation.ispartofjournalExperimental Gerontology
dc.subject.fieldofresearchCentral Nervous System
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchcode110903
dc.subject.fieldofresearchcode11
dc.titleStem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.description.notepublicThis publication has been entered into Griffith Research Online as an Advanced Online Version.
gro.hasfulltextNo Full Text
gro.griffith.authorPetcu, Eugen B.
gro.griffith.authorPopa-Wagner, Aurel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record